Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Figures corrected afterwards (2024).
Gross margin
€ 641,586
▲ 15% vs 2024
Profit
Caution€ -2.6 million
▼ 3% vs 2024
Debts
Low€ 917,511
▲ 132% vs 2024
NEUVASQ BIOTECHNOLOGIES from Charleroi, company number BE0762966663, closed financial year 2025 with a result of € -2.6 million after tax. For that financial year NEUVASQ BIOTECHNOLOGIES recorded a gross margin of € 641,586 and equity of € 6.3 million. Compared with financial year 2024, the result moved from € -2.5 million to € -2.6 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.
What happened at NEUVASQ BIOTECHNOLOGIES?
What happened at NEUVASQ BIOTECHNOLOGIES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- GEMA SRL stepped down as director. NBB
- Yves Ribeill stepped down as director. NBB
- NEWTON BIOCAPITAL PARTNER SRL stepped down as director. NBB
- Benoit Vanhollebeke stepped down as director. NBB
- SPARAXIS SA stepped down as director. NBB
- 50°NORTH VENTURES stepped down as director. NBB
- SFPI SA stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 2.6 million. Source: NBB ↗
In short
From € 463,776 loss in 2021 to € 2.6 million loss in 2025.
On average € 69,000 of value added per employee in 2025.
A new publication or filing at NEUVASQ BIOTECHNOLOGIES? We notify you, reason included.
Follow NEUVASQ BIOTECHNOLOGIESNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Chairman of the board · represented by Michel Allé
Also active at: D'Ieteren Group, EURVEST, EPICS THERAPEUTICS +2 more
since 2022 · until 2028
Director · represented by Pierre Detrixhe
Also active at: SYNERGIA MEDICAL, Newton Biocapital I, pricaf privée de droit belge, Newton Biocapital I Investment Pool +4 more
since 2025 · until 2027
Benoit Vanhollebeke
Director
since 2021 · until 2027
Director · represented by Christina Franssen
Also active at: C.P. Bourg, A.M.B., Jean Goldschmidt International +228 more
since 2021 · until 2027
Director · represented by Denis Bedoret
Also active at: EEBIC, BE ANGELS, Brussels South Charleroi BioPark Dev +18 more
since 2021 · until 2027
Director · represented by Francois Fontaine
Also active at: Aviapartner Belgium, Société Anonyme Belge de Constructions Aéronautiques, Société Nationale de Construction Aérospatiale +62 more
since 2025 · until 2027
Yves Ribeill
Director
since 2022 · until 2028
Establishments
Establishment units
Physical locations of this company
Rue Auguste Piccard 48
6041 Charleroi
Rue Adrienne Bolland 8
6041 Charleroi
Active since 1 January 2023
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
SYNABS
€ 742,551 gross margin · 2025
European Infrared Technologies
€ 53,354 gross margin · 2024
HEARTKINETICS
€ -463,720 gross margin · 2022
Genflow Biosciences
€ -264,246 gross margin · 2025
CANCER STATE THERAPEUTICS
€ -105,252 gross margin · 2025
+1 more
Details
- Company number
- 0762.966.663
- VAT number
- BE 0762.966.663
- Registered office
- Rue Auguste Piccard 48, 6041 Charleroi
- Names & denominations
- NEUVASQ BIOTECHNOLOGIES
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 5 February 2021
- Peppol
- Active · Active since 15 Mar 2021
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten op het gebied van voeding
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Activiteiten van medische beeldvorming en medische laboratoria
Overige zakelijke dienstverlening, neg
+3